|
2007 Journal Article How to treat: Resistant hypertensionJohnson, David W. (2007). How to treat: Resistant hypertension. Australian Doctor, 20, 27-28, 30-32, 34. |
|
2007 Journal Article Resistant hypertensionJohnson D.W. (2007). Resistant hypertension. Australian Doctor (20/APR) |
|
2007 Journal Article Drug dosing adjustment in people with reduced GFRMathew, Timothy, Jones, Graham and Johnson, David (2007). Drug dosing adjustment in people with reduced GFR. Australian Prescriber, 30 (2), 34-34. |
|
2007 Journal Article Isolation, propagation and characterization of primary tubule cell culture from human kidney (Methods in Renal Research)Qi, Weier, Johnson, David W., Vesey, David A., Pollock, Carol A. and Chen, Xinming (2007). Isolation, propagation and characterization of primary tubule cell culture from human kidney (Methods in Renal Research). Nephrology, 12 (2), 155-159. doi: 10.1111/j.1440-1797.2007.00779.x |
|
2007 Journal Article Potential physiological and pathophysiological roles for protease-activated receptor-2 in the kidneyVesey, David A., Hooper, John D., Gobe, Glenda C. and Johnson, David W. (2007). Potential physiological and pathophysiological roles for protease-activated receptor-2 in the kidney. Nephrology, 12 (1), 36-43. doi: 10.1111/j.1440-1797.2006.00746.x |
|
2007 Journal Article Silibinin inhibits renal cell carcinoma via mechanisms that are independent if insulin-like growth factor-binding protein 3Cheung, Catherine W., Vesey, David A., Nicol, David L. and Johnson, David W. (2007). Silibinin inhibits renal cell carcinoma via mechanisms that are independent if insulin-like growth factor-binding protein 3. BJU International, 99 (2), 454-460. doi: 10.1111/j.1464-410X.2007.06571.x |
|
2007 Conference Publication Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patientsHourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Gandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients. American Transplant Congress, San Francisco, CA, USA, 5-9 May 2007. Oxford, England: Wiley-Blackwell. doi: 10.1111/j.1600-6143.2007.01811.x |
|
2007 Conference Publication Intravenous versus oral iron supplementation in peritoneal dialysis patientsJohnson, David W. (2007). Intravenous versus oral iron supplementation in peritoneal dialysis patients. The 11th Congress of the International Society for Peritoneal Dialysis, Hong Kong, 25-29 August, 2006. Milton, Ontario: Multimed Inc.. |
|
2007 Journal Article Update for GPs on the management of mild to moderate renal impairment.Mathew, T. and Johnson, D. (2007). Update for GPs on the management of mild to moderate renal impairment.. Medical Observer, 31-34. |
|
2007 Book Chapter Peritoneal dialysisJohnson, David, Chang, Sean, Excell, Leonie, Livingston, Brian, Bannister, Kym and McDonald, Stephen (2007). Peritoneal dialysis. Australia and New Zealand Dialysis and Transplant Registry: The 30th report 2007. (pp. 6-2-6-18) edited by Stephen McDonald, Sean Chang and Leonie Excell. Adelaide, Australia: ANZDATA Registry. |
|
2007 Conference Publication Collapsing glomerulopathy secondary to human parvovirus b19 in a kidney-pancreas transplant recipientKaisar, M. O., Hawley, C. M., Mudge, D. W., Campbell, S. B., Johnson, D. W. and Isbel, N. M. (2007). Collapsing glomerulopathy secondary to human parvovirus b19 in a kidney-pancreas transplant recipient. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell. |
|
2007 Journal Article Central obesity is common in renal transplant recipients and is associated with increased prevalence of cardiovascular risk factorsOrazio, Linda, Armstrong, Kirsty, Banks, Merrilyn, Johnson, David, Isbel, Nikky and Hickman, Ingrid (2007). Central obesity is common in renal transplant recipients and is associated with increased prevalence of cardiovascular risk factors. Nutrition & Dietetics, 64 (3), 200-206. doi: 10.1111/j.1747-0080.2007.00151.x |
|
2007 Journal Article Evaluation of renal function: CARI guidelinesJohnson, David W. (2007). Evaluation of renal function: CARI guidelines. Australian Family Physician, 36 (1-2), 46-46. |
|
2007 Conference Publication MSC protect renal tubular epithelium from oxidative stress in vitro: support for a protective or regenerative role in acute renal failureLiu, H., McTaggart, S., Li, J., Johnson, D. W. and Gobe, G. C. (2007). MSC protect renal tubular epithelium from oxidative stress in vitro: support for a protective or regenerative role in acute renal failure. World Congress of Nephrology 2007, Rio de Janeiro, Brazil, 21-25 April 2007. International Society of Nephrology. |
|
2007 Conference Publication Access infection in dialysis patients: A comparison of peritoneal vs haemodialysis in a large dialysis populationClark, C. J., Johnson, D., Hawley, C., May, K., Campbell, S., Isbel, N., Mudge, D. and Burke, J. (2007). Access infection in dialysis patients: A comparison of peritoneal vs haemodialysis in a large dialysis population. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell Publishing. |
|
2007 Conference Publication Erythropoietin: Novel applications beyond anaemia treatmentVesey, D. A., Gobe, G. C. and Johnson, D. W. (2007). Erythropoietin: Novel applications beyond anaemia treatment. 2nd International Conference of Naresuan University, Phitsanulok, Thailand, 27-28 July, 2007. |
|
2007 Journal Article Modification of cardiovascular risk in hemodialysis patients: an evidence-based reviewJohnson, David W., Craven, Ann-Maree and Isbel, Nicole Maree (2007). Modification of cardiovascular risk in hemodialysis patients: an evidence-based review. Hemodialysis International, 11 (1), 1-14. doi: 10.1111/j.1542-4758.2007.00146.x |
|
2007 Conference Publication Vascular and structural cell response to erythropoietin in the neonatal brain during hypoxic injuryYamada, M., Burke, C., Colditz, P., Johnson, D. W. and Gobe, G. C. (2007). Vascular and structural cell response to erythropoietin in the neonatal brain during hypoxic injury. Australian Society of Medical Research Annual Scientific Meeting, Blue Mountains, NSW, November, 2007. |
|
2007 Conference Publication Follow-up of 15 years of live donors in a large Australian renal transplant unitKaisar, M. O., Isbel, N., Hawley, C., Johnson, D., Mudge, D., Griffin, A., Wall, D., Preston, J., Nicol, D. and Campbell, S. (2007). Follow-up of 15 years of live donors in a large Australian renal transplant unit. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell. |
|
2007 Conference Publication TRAFs, CARDs and CIDEs are novel apoptotic gene families in therapy-treated renal cell carcinoma and potential diagnostic markersRajandram, R., Pat, B. K., Li, J., Percy, C. J., Johnson, D. W. and Gobe, G. C. (2007). TRAFs, CARDs and CIDEs are novel apoptotic gene families in therapy-treated renal cell carcinoma and potential diagnostic markers. National Cancer Research Institute Conference, Birmingham, England, 2-5 October, 2007. |
